---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-011857"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2022-03-11T23:59:59+00:00"
generated_at: "2026-06-26T23:34:50.708574+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma shareholders approve reverse stock split of 1-for-5 to 1-for-50

## Summary
- Shareholders granted Board discretion to effect a reverse split at a ratio between 1:5 and 1:50.
- Reverse split must be completed by February 8, 2023.
- Vote totals: 53,847,792 in favor, 11,915 against, 240 abstain.
- Quorum of 53,859,947 shares represented at the special meeting.

## SEC filing metadata
- accession: 0001213900-22-011857
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2022-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390022011857/0001213900-22-011857-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390022011857/ea156769-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-011857
- JSON: https://secwatch.observer/filing/0001213900-22-011857.json
- Plain text: https://secwatch.observer/filing/0001213900-22-011857.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.